Celator Pharmaceuticals, Inc.
CELATOR¨ is a privately held biopharmaceutical company working to develop new and more effective combination therapies to treat cancer. Celator pursues a wide range of product development opportunities based on a portfolio of delivery technologies including liposomes, polymers and nanotechnologies (nanoparticles).
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||